Press Releases

Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD(recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS)....

Sanofi and Bristol-Myers Squibb Company today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets. Under the terms of the revised agreement,...

CiToxLAB Group, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated first half 2012 revenues reached EUR 37.2M (USD 48.4 million approximately). This marks a 34 per cent increase compared with the...

AIBioTech is quickly gaining ground in the niche market of custom synthesis of small molecules, including molecules which contain stable isotopes of particular atoms. The products of these syntheses are routinely used by our customers...

Endo Tools Therapeutics, a developer of advanced, minimally-invasive medical devices to treat obesity, digestive tract tumors and type II diabetes, announces today the completion of several first-in-human cases where Endo Tools' new Endomina(TM) triangulation platform has been used....

  Biophytis, a research company in health and nutrition focusing on metabolic disorders and age-related diseases, announces today that it has raised EUR two million (USD 2.6M) in a B round. Metabrain Research, a spin-off of Merck Serono based...

Impax Laboratories, Inc.today announced that it and Teva Pharmaceuticals USA, Inc. have reached agreement with Janssen Pharmaceuticals, Inc. and ALZA Corporation (together, “ALZA”) to settle pending U.S. litigation with regard to the production and sale of generic formulations...